Using zebrafish as a model, we previously reported that developmental exposure to triphenyl phosphate (TPP) -a high-production volume organophosphate-based flame retardant -results in dioxin-like cardiac looping impairments that are independent of the aryl hydrocarbon receptor. Using a pharmacologic approach, the objective of this study was to investigate the potential role of retinoic acid receptor (RAR) -a nuclear receptor that regulates vertebrate heart morphogenesis -in mediating TPP-induced developmental toxicity in zebrafish. We first revealed that static exposure of zebrafish from 5-72 h post-fertilization (hpf) to TPP in the presence of non-toxic concentrations of an RAR antagonist (BMS493) significantly enhanced TPP-induced toxicity (relative to TPP alone), even though identical non-toxic BMS493 concentrations mitigated retinoic acid (RA)-induced toxicity. BMS493-mediated enhancement of TPP toxicity was not a result of differential TPP uptake or metabolism, as internal embryonic doses of TPP and diphenyl phosphate (DPP) -a primary TPP metabolite -were not different in the presence or absence of BMS493. Using real-time PCR, we then quantified the relative change in expression of cytochrome P450 26a1 (cyp26a1) -a major target gene for RA-induced RAR activation in zebrafish -and found that RA and TPP exposure resulted in a ∼5-fold increase and decrease in cyp26a1 expression, respectively, relative to vehicle-exposed embryos. To address whether TPP may interact with human RARs, we then exposed Chinese hamster ovary cells stably transfected with chimeric human RAR␣-, RAR␤-, or RAR␥ to TPP in the presence of RA, and found that TPP significantly inhibited RA-induced luciferase activity in a concentration-dependent manner. Overall, our findings suggest that zebrafish RARs may be involved in mediating TPP-induced developmental toxicity, a mechanism of action that may have relevance to humans.
Introduction
Triphenyl phosphate (TPP) is an unsubstituted aryl phosphate ester historically used as a high-production volume flame retardant within polyvinyl chloride, polymers, printed circuit boards, photographic films, and hydraulic fluids (Brooke et al., 2009 ). Based on estimates from 10 to15 years ago, the combined production and use of TPP within Western Europe was 20,000-30,000 tons (or 44-66 Abbreviations: AHR, aryl hydrocarbon receptor; BMS4934, -[(1E)-2-[5,6-dihydro-5,5-dimethyl8-(2-phenylethynyl)-2-naphthalenyl]ethenyl]benzoic acid; cyp26a1, cytochrome P450 26a1; DMSO, dimethyl sulfoxide; DPP, diphenyl phosphate; hpf, hours post-fertilization; MS-222, tricaine methanesulfonate; RA, retinoic acid; RAR, retinoic acid receptor; TPP, triphenyl phosphate.
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million pounds) in 2000, while the combined production and use of TPP within the United States alone was 4500-22,700 tons (or 10-50 million pounds) (van der Veen and de Boer, 2012) . Since 2005, the use of TPP as a flame retardant within polyurethane foam likely increased within the United States following the phase-out of pentabrominated diphenyl ether and subsequent replacement with alternative TPP-containing flame retardant formulations (USEPA, 2005) . Similar to pentabrominated diphenyl ether, TPP is an additive flame retardant that can migrate from end-use products into indoor and outdoor environmental media (van der Veen and de Boer, 2012). As such, environmental exposure to TPP may pose a health risk to humans and ecological species, particularly during sensitive windows of development. Using zebrafish embryos, we recently evaluated the potential developmental toxicity of brominated and aryl phosphate components (including TPP) present within Firemaster 550 (McGee et al., 2013) , an increasingly used alternative formulation for polyurethane foam. Within this study, exposure to TPP and mono-isopropylated triaryl phosphate -but not the remaining brominated and aryl phosphate components of Firemaster 550 -blocked normal looping of the atrium and ventricle, resulting in a "tube heart" phenotype. In addition, heart malformations resulting from mono-isopropylated triaryl phosphate exposure -but not TPP exposure-were blocked in the presence of an aryl hydrocarbon receptor (AHR) antagonist (1-methyl-N-[2-methyl-4-[2-(2-methylphenyl) diazenyl]phenyl-1H-pyrazole-5-carboxamide, or CH223191). Therefore, since TPP-induced malformations appear to be AHR-independent, it is currently unclear how TPP induces developmental toxicity in zebrafish and whether this mechanism of action is conserved within other vertebrates.
Although TPP is known to activate human pregnane X receptor (Honkakoski et al., 2004; Kojima et al., 2013) and peroxisome proliferator-activated receptor (Belcher et al., 2014; Pillai et al., 2014) , these two receptors are not known to play a major role in regulating cardiac development within vertebrates. However, retinoic acid receptor (RAR) is a ligand-activated nuclear receptor that; (1) directly controls heart morphogenesis in zebrafish (Stainier and Fishman, 1992) and mice (Niederreither et al., 2001) ; (2) when over-activated by excess retinoic acid (RA), blocks normal cardiac looping within zebrafish (Chen et al., 2008) ; and (3) is activated by structurally diverse xenobiotics (Kamata et al., 2008) . While mammals have three RAR orthologs (RAR␣-, RAR␤-, and RAR␥) (Bastien and Rochette-Egly, 2004) , zebrafish lack RAR␤ and possess two different paralogs of RAR␣ (raraa and rarab) and RAR␥ (rarga and rargb) (Waxman and Yelon, 2007) . Despite these differences, cytochrome P450 26a1 (cyp26a1) is a major target gene for RA-induced RAR activation in zebrafish (White et al., 1996) , mice (Ray et al., 1997) , and humans (White et al., 1997) , representing a biomarker for assessing potential RAR activation in vivo.
Based on our previous findings relative to data available within the literature, the overall objective of this study was to begin investigating the potential role of RAR in mediating TPP-induced developmental toxicity in zebrafish. To accomplish this objective, we relied on a combination of high-content screening assays, real-time PCR, and human RAR reporter assays to test the hypothesis that TPP-mediated RAR activation results in developmental toxicity, a mechanism that, similar to our findings with monoisopropylated triaryl phosphate (McGee et al., 2013) , may have relevance to humans. We also quantified internal embryonic doses of TPP and diphenyl phosphate (DPP) -a primary TPP metabolite -to confirm uptake of TPP and determine whether TPP and DPP doses were affected by the presence of an RAR antagonist.
Materials and methods

Animals
For all assays described below, we relied on a robust line of transgenic zebrafish (fli1:egfp) that stably express enhanced green fluorescent protein within vascular endothelial cells (Lawson and Weinstein, 2002) . Although we did not assess the potential impacts of chemical exposure on angiogenesis within this study, we relied on fluorescent fli1:egfp zebrafish to analyze heart rate and body length using previously optimized protocols (Yozzo et al., 2013) . Adult fli1:egfp zebrafish were maintained on a 14-h:10-h light:dark cycle within a five-shelf stand-alone system (Aquatic Habitats, Inc., Apopka, FL, USA) containing photoperiod light-cycle enclosures and recirculating conditioned reverse osmosis water. Dissolved oxygen, pH, conductivity, salinity, alkalinity, and temperature within recirculating water were maintained at 4-6 mg/L, 6.5-7.5, 425-475 S, <1 ppt, 50-100 mg/L, and 27-28 • C, respectively; in addition, levels of ammonia, nitrite, and nitrate within recirculating water were consistently below 0.1 mg/L, 0.05 mg/L, and 2 mg/L, respectively. Adult females and males were bred directly on-system using intank breeding traps suspended within 3-L tanks, or bred off-system within a light-and temperature-controlled incubator using breeding traps suspended within 1-L tanks. For all experiments described below, newly fertilized eggs were staged according to previously described methods (Kimmel et al., 1995 
Image acquisition
At 72 hpf, the plate was removed from the incubator, and zebrafish embryos were anesthetized with 100 mg/L MS-222 by adding 25 L of 300 mg/L MS-222 to 50 L of vehicle or treatment solution. The plate was then centrifuged at 200 rpm for 2 min to help orient hatched embryos into right or left lateral recumbency. Using automated image acquisition protocols and parameters previously optimized (Yozzo et al., 2013) for our ImageXpress Micro Widefield High-Content Screening System (Molecular Devices, Sunnyvale, CA, USA), each embryo was imaged to analyze the following endpoints: heart rate, pericardial area, and body length. During the entire image acquisition period, internal temperature within the ImageXpress Micro system was maintained between 25 and 27 • C by removing panels on both sides of the ImageXpress Micro system and blowing air from left to right through the ImageXpress Micro with a portable fan; internal temperature was monitored and recorded at initiation and termination of each imaging protocol using a digital thermometer. Following completion of image acquisition, 72-hpf embryos were then euthanized by placing the plate at 4 • C for 30 min.
Data extraction
Within MetaXpress 4.0.0.24 software (Molecular Devices, Sunnyvale, CA, USA), custom journal scripts for extraction of heart rate, pericardial area, and body length data were used as previously described (Yozzo et al., 2013) . Prior to data extraction, stream acquisitions within each well were inspected within MetaXpress to assess embryo orientation and survival. Coagulated embryos, unhatched embryos, grossly malformed embryos, or developed embryos lacking a heartbeat were not included in the analysis. Using these criteria, only hatched and live embryos positioned in right or left lateral recumbency were analyzed. Interactive semiautomated journal scripts were used to isolate regions of interest and quantify heart rate and pericardial area, whereas a fully automated journal script was used to quantify body length. Examples of raw and analyzed images for each endpoint as well as additional details of the data extraction and analysis process have been previously described (Yozzo et al., 2013) .
BMS493 co-exposures
We used a pan-RAR antagonist (BMS493) to determine whether TPP-induced developmental toxicity was RAR-dependent. Based on exposures described in Section 2.3 and using pericardial area as an endpoint, non-toxic BMS493 concentrations selected for co-exposure experiments were 0.19 and 0.39 M. Using identical exposure set-up and image acquisition protocols described in Section 2.3, we exposed embryos to RA (25, 50, or 100 nM) or TPP (3.125, 6.25, or 12.5 M) in the presence or absence of 0.19 or 0.39 M BMS493. For TPP-BMS493 co-exposures, we extracted and analyzed data for pericardial area, as this endpoint represented a readily measurable biomarker for cardiac looping defects. For RA-BMS493 co-exposures, we manually quantified the distance from the caudal fin to the anteroposterior axis within MetaXpress ( Fig. S1 ) since RA disrupted normal caudal fin development in the absence of detectable effects on heart rate and pericardial area.
Quantification of internal embryonic doses of TPP and DPP
To quantify internal embryonic doses of TPP and DPP, 5-hpf fli1:egfp embryos (20 embryos per well; six wells per treatment) were arrayed into a clear 48-well Falcon tissue culture plate (Corning Life Sciences, Tewksbury, MA, USA) containing 1 mL per well of vehicle (0.1% DMSO) or 12.5 M TPP in the presence or absence of 0.39 M BMS493. Embryos were incubated at 28 • C under a 14-h:10-h light:dark cycle and static conditions until 72 hpf, and then euthanized with an overdose of MS-222. For each replicate pool (three per treatment), 30 72-hpf embryos were combined from two replicate wells into a 2-mL cryovial, immediately snap-frozen in liquid nitrogen, and stored at −80 • C until analysis.
Immediately prior to extraction, samples were spiked with deuterated TPP (d 15 -TPP) and deuterated DPP (d 10 -DPP). Analytes were extracted and quantified using previously published methods (Dishaw et al., 2014; McGee et al., 2012) . Briefly, tissue homogenates were sonicated three times in 1 mL acetonitrile for 20 min. Combined acetonitrile extracts were concentrated to dryness under N 2 at 35 • C and reconstituted in 1:1 methanol:water. Prior to analysis, particulates were removed using a 0.2-M nylon membrane. Tissue extracts were analyzed using liquid chromatography-tandem mass spectrometry (LC/MS-MS) on an Agilent 1200 series LC connected to an Agilent 6410B triple quadrupole MS detector equipped with an electrospray ionization source. Analytes were separated chromatographically on a Kinetex XB-C18 column (100 mm × 2.1 mm, 2.6 m; Phenomenex) using a methanol-water gradient. Analytes were detected using multiple reaction monitoring in positive (TPP and d 15 -TPP) and negative (DPP and d 10 -DPP) ionization modes. Method detection limits (MDLs) were defined as three times the standard deviation of lab blanks (if present) or three times the noise. MDLs for TPP and DPP were 1.7 and 0.15 ng, respectively.
Total RNA isolation and real-time PCR
To assess the potential effects of RA and TPP on cyp26a1 expression, 5-hpf fli1:egfp embryos (20 embryos per well; 12 wells per treatment) were arrayed into a clear 48-well Falcon tissue culture plate (Corning Life Sciences, Tewksbury, MA, USA) containing 1 mL per well of vehicle (0.1% DMSO), 100 nM RA, or 12.5 M TPP. Embryos were incubated at 28 • C under a 14-h:10-h light:dark cycle and static conditions until 72 hpf, and then euthanized with an overdose of MS-222, immediately snap-frozen in liquid nitrogen, and stored at −80 • C until RNA extraction procedures.
After combining three replicate wells per pool, four replicate pools of 60 72-hpf embryos per pool were homogenized in 2-mL cryovials using a PowerGen Homogenizer (Thermo Fisher Scientific, Waltham, MA, USA). Following homogenization, a SV Total RNA Isolation System (Promega, Madison, WI, USA) was used to extract total RNA from each replicate sample per manufacturer's instructions. First-strand cDNAs were generated from total RNA using oligo(dT) 15 primers and AMV Reverse Transcriptase (Promega, Madison, WI, USA) and stored at −20 • C until use. cyp26a1 and 18 s rRNA cDNAs were amplified using the following primers: cyp26a1, forward primer 5 -GATGCTCTGGAGCACTACATTC-3 , reverse primer 5 -GTTCTTGCTCGTCCGTCTTTAT-3 ; and 18 s rRNA, forward primer, 5 -TCGCTAGTTGGCATCGTTTATG-3 , reverse primer 5 -CGGAGGTTCGAAGACGATCA-3 . 18 s rRNA was selected as an internal control because it is stably expressed throughout zebrafish embryogenesis (McCurley and Callard, 2008) . Per manufacturer's instructions, approximately 150 ng of cyp26a1 and 18 s rRNA cDNA was PCR amplified in duplicate using GoTaq qPCR Master Mix (Promega, Madison, WI, USA) and an Applied Biosystems 7900HT Fast Real-Time PCR System (Life Technologies, Grand Island, NY, USA). Real-time PCR reaction conditions were 2 min at 95 • C followed by 45 cycles of 95 • C for 30 s, 51 • C for 30 s, and 72 • C for 30 s. Relative quantitation of gene expression within each treatment was calculated using the comparative cycle threshold method as previously described (Jayasinghe and Volz, 2012) .
Human RAR reporter assays
A cell-based human RAR-driven luciferase reporter assay developed and conducted by the Services Group within INDIGO Biosciences (State College, PA) was used to determine whether TPP antagonized RA-induced activation of human RAR␣-, RAR␤-, or RAR␥. 9-cis RA was used as an agonist for RAR␣, whereas all-trans RA was used as an agonist for -(3-quinolinyl)-2-naphthalenyl]carbonyl]amino]benzoic acid (BMS195614) was used as a reference antagonist for RAR␣, and 4-[6-[(2-methoxyethoxy) methoxy]-7-tricyclo[3.3.1.13,7]dec-1-yl-2-naphthalenyl) benzoic acid (CD2665) was used as a reference antagonist for RAR␤ and RAR␥. Concentrated TPP stock was serially diluted in DMSO to yield 3.1, 6.3, 13, 25, 50, and 100 mM working stocks, and concentrated reference antagonist stocks were serially diluted in DMSO to yield 0.0006, 0.002, 0.01, 0.04, 0.16, 0.63, 2.5, and 10 mM working stocks. Treatment solutions were prepared by diluting working stocks in INDIGO's proprietary culture media, resulting in 0.1% DMSO within all wells. For positive control wells, 9-cis or all-trans RA was added at a final concentration that increased luminescence by ∼80% relative to negative control wells. Treatment wells contained identical 9-cis or all-trans RA concentrations as positive control wells, but also contained TPP (3.1, 6.3, 13, 25, 50, or For each treatment group, spiked culture media (100 L) was dispensed into triplicate assay wells (using a white 96-well microplate) containing Chinese hamster ovary cells stably transfected with (1) expression vector containing the N-terminal GAL4 DNA binding domain fused to the ligand binding domain of human RAR␣-, RAR␤-, or RAR␥ and (2) reporter vector containing a firefly luciferase gene functionally linked to the GAL4-specific upstream activation sequence. Following a 24-h incubation at 37 • C under 5% carbon dioxide (CO 2 ), treatment media was discarded and, following one rinse with INDIGO's proprietary live cell multiplex buffer, live cell multiplex substrate was added to each well of the assay plate to assess cell viability. Following incubation at 37 • C for 30 min, fluorescence was quantified to determine the relative number of live cells per well, and then live cell multiplex substrate was discarded and 100 L of ONE-Glo Luciferase Assay Reagent (Promega, Madison, WI, USA) was added to each well of the assay plate. After a 5-min incubation at room temperature, luminescence was quantified using a Glomax 96 microplate luminometer (Promega, Madison, WI, USA). Mean fluorescence and luminescence (±standard deviation) values were calculated for each treatment group based on triplicate wells per treatment. For cell viability data, mean fluorescence for each treatment group was normalized to mean fluorescence for RA-only wells to determine the percent change in cell viability relative to positive control wells.
Statistical analyses
All statistical procedures were performed using SPSS Statistics 21. A general linear model (GLM) analysis of variance (ANOVA) (˛= 0.05) was used for all data derived from high-content screening assays, real-time PCR, analytical chemistry, and human RAR reporter assays, as these data did not meet the equal variance assumption for non-GLM ANOVAs. Pair-wise Tukey-based multiple comparisons of least square means were performed to identify significant treatment-related effects relative to vehicle controls, as well as BMS493-related effects relative to corresponding treatments without BMS493.
Results
RA, TPP, and BMS493 are toxic to developing zebrafish embryos
RA resulted in 56-72% survival following exposure to 0.78-50 nM, whereas exposure at the highest concentration (100 nM) resulted in <50% survival (Fig. 1A) . Body length (Fig. 1B) and pericardial area (Fig. 1D) were also significantly decreased and increased, respectively, at 100 nM. However, RA exposure resulted in no effect on heart rate at all concentrations tested (Fig. 1C) , and no effect on body length and pericardial area at concentrations ≤50 nM. A representative image of a 72-hpf embryo treated with 50 nM RA is provided in Fig. S2 .
TPP resulted in <50% survival at the highest concentration tested (50 M) ( Fig. 2A) , while body length was significantly decreased at 25 and 50 M (Fig. 2B) . Pericardial area was significantly increased in a concentration-dependent manner at concentrations >3.125 M (Fig. 2D) . However, similar to RA, TPP exposure resulted in no significant effects on heart rate at all concentrations tested (Fig. 2C) . A representative image of a 72-hpf embryo treated with 12.5 M TPP is provided in Fig. S2 .
BMS493 was significantly more toxic than TPP, resulting in a steep concentration-dependent effect on survival and 100% mortality following exposure to >1.56 M (Fig. 3A) . While body length was not affected following exposure to ≤1.56 M (Fig. 3B) , BMS493 exposure resulted in a significant increase in pericardial area at concentrations ≥0.78 M (Fig. 3D) . Moreover, while pericardial area was not affected at 0.39 M and lower, BMS493 exposure significantly decreased heart rate by 25-50 beats per minute (bpm) relative to vehicle controls at all concentrations except 0.05 and 0.78 M (Fig. 3C) . A representative image of a 72-hpf embryo treated with 1.56 M BMS493 is provided in Fig. S2 .
BMS493 enhances TPP-induced toxicity in zebrafish embryos
While exposure to 50 and 100 nM RA alone resulted in a decrease in percent survival and increase in distance from the caudal fin to the anteroposterior axis ( Fig. 4A and B) , non-toxic concentrations of BMS493 (0.19 and 0.39 M) mitigated RA-induced mortality (≥75% survival across all co-exposures) and caudal fin malformations in a concentration-dependent manner (Fig. 4B) . However, unlike RA, co-exposure of embryos to 3.125-12.5 M TPP and non-toxic concentrations of BMS493 resulted in a significant increase in pericardial area (Fig. 4C and D) -an effect that was further enhanced by increasing BMS493 concentrations. Representative images of 72-hpf embryos treated with 100 nM RA or 12.5 M TPP in the presence or absence of 0.39 M BMS493 are provided in Fig. S3 . (Fig. 5) . Mean internal embryonic doses of DPP within these same treatments were <MDL, 1.75, <MDL, and 0.93, respectively (Fig. 5) . Although TPP doses were significantly higher in both TPP treatments relative to vehicle controls, there were no significant differences in TPP and DPP doses within the TPP-BMS493 co-exposure compared to TPP alone (Fig. 5) . Therefore, the presence of non-toxic BMS493 concentrations within the exposure media did not affect internal doses of TPP and DPP within 72-hpf embryos.
TPP exposure decreases cyp26a1 expression in zebrafish embryos
As described in Section 3.2, co-exposure to BMS493 did not mitigate -but rather enhanced -TPP-induced developmental toxicity in zebrafish. As a result, we quantified the potential effect of RA and TPP on cyp26a1 expression in order to (1) confirm that RA exposure resulted in an increase in cyp26a1 expression and (2) test the hypothesis that TPP exposure decreased cyp26a1 expression. Indeed, while RA exposure resulted in a ∼5-fold increase in cyp26a1 expression (Fig. 6) , TPP exposure resulted in a ∼5-fold decrease in cyp26a1 expression (Fig. 6) .
TPP inhibits RA-induced activation of human RAR˛-, RARˇ-, and RAR
Using Chinese hamster ovary cells stably transfected with chimeric human RAR␣-, RAR␤-, or RAR␥, TPP significantly inhibited RA-induced luciferase activity at 50 and 100 M for human RAR␣ and RAR␤ and 100 M for human RAR␥ (Fig. 7) . Cell viability (percent live cells) was ≥86% across all three assays for reference antagonist exposures and all TPP concentrations except for the highest concentration (100 M); within this TPP concentration, cell viability was ≥74% across all three assays (Table S1 ).
Discussion
Within this study, we found that TPP exposure was toxic to developing zebrafish embryos, albeit at high nominal aqueous concentrations. Although the toxicity of TPP within adult animals (including zebrafish) has been extensively evaluated (Brooke et al., 2009; Liu et al., 2012 Liu et al., , 2013 USEPA, 2005) , to our knowledge the potential toxicity of TPP during early vertebrate development has received little attention. To date, only one prenatal developmental toxicity study and one fish early life-stage study using rats and fathead minnows, respectively, have reported adverse findings (Brooke et al., 2009; USEPA, 2005) . Within Sprague-Dawley rats, daily exposure to 690 mg/kg/day TPP (the highest dose tested) decreased dam body weight in the absence of teratogenic effects, suggesting that maternal metabolism mitigated in utero exposure via transformation of TPP into non-toxic metabolites. Within fathead minnows, TPP significantly decreased post-hatch (fry) survival at 230 g/L (the highest concentration tested) in the absence of effects on embryo hatchability, body length, and eye development, suggesting that the highest TPP concentration tested was unable to penetrate the embryonic chorion during development. While our findings demonstrate that TPP is toxic to developing zebrafish embryos at higher concentrations (e.g., 12.5 M TPP = 4,078 g/L TPP), the acute or chronic risk of TPP to fish embryos and larvae within aquatic environments is likely negligible since short-and long-term surface water TPP concentrations are expected to be <10 g/L (Brooke et al., 2009; USEPA, 2005) .
While administration of exogenous RA was highly toxic at nominal concentrations >50 nM, BMS493 was significantly more potent than TPP and required an approximately 30-fold lower nominal concentration to induce a similar magnitude of toxicity. Broadly classified as an RAR antagonist, BMS493 is a pan-RAR inverse agonist that, upon interaction with the RAR ligand-binding domain, represses RAR function and decreases expression of RAR target genes relative to basal transcriptional levels (Germain et al., 2009; le Maire et al., 2010) . While we did not assess the specificity of BMS493 to zebrafish RARs, previous studies published nearly 15 years ago confirmed that BMS493 is a potent inhibitor of RA signaling in vivo within mouse, chick, and zebrafish embryos (Dupe and Lumsden, 2001; Grandel et al., 2002 ; Stafford and . No significant differences in TPP or DPP were detected within the TPP-BMS493 co-exposure compared to TPP alone. N = three replicate pools per treatment. MDL = method detection limit. Prince, 2002; Wendling et al., 2000 Wendling et al., , 2001 . Therefore, in our study, BMS493-induced toxicity at higher concentrations was likely due to abolishment of endogenous RA signaling required for normal embryonic development and survival.
Based on our previously published findings (McGee et al., 2013) , we hypothesized that aberrant activation of RAR may mediate TPP-induced developmental toxicity. Contrary to our hypothesis, co-exposure of developing embryos to TPP and non-toxic BMS493 concentrations significantly enhanced toxicity relative to TPP alone, even though BMS493 mitigated RA-induced malformations. In addition, while RA exposure increased cyp26a1 expression by ∼5-fold, TPP exposure decreased cyp26a1 expression by ∼5-fold, suggesting that TPP may have repressed RAR function -either directly or indirectly -relative to basal levels within vehicle-exposed embryos. Similar to the effect of TPP on cyp26a1 expression, our previous findings showed that exposure of zebrafish embryos to 4 M TPP within glass beakers decreased cyp1a (a major AHR target gene) expression by ∼7-fold (McGee et al., 2013) , suggesting that TPP may affect crosstalk between the AHR and RAR during embryogenesis. Indeed, available data within the published literature supports this hypothesis, as endogenous RA and normal RAR function are required for expression of AHR mRNA and proper embryonic development in mice and fish (Hayashida et al., 2004; Jacobs et al., 2011) .
Within hepatocytes, TPP undergoes rapid enzyme-mediated hydrolysis and hydroxylation to form DPP and hydroxyl TPP metabolites, respectively (Sasaki et al., 1984; Su et al., 2014; Van den Eede et al., 2013) . Urinary TPP and DPP concentrations were recently measured within several adult human populations (Hoffman et al., 2014a,b,b; Meeker et al., 2013) , and results from these studies suggest that DPP may be a reliable indicator of human TPP exposure within indoor environments. Therefore, for this study, we relied on DPP as an indicator of potential TPP metabolism within developing zebrafish embryos. To determine whether BMS493 interfered with TPP uptake and/or metabolism, we quantified internal embryonic doses of TPP and DPP in 72-hpf embryos following a 5-72-hpf static exposure to vehicle or TPP in the presence or absence of BMS493. Interestingly, co-exposure with non-toxic concentrations of BMS493 did not affect internal doses of TPP or DPP, suggesting that (1) TPP is not metabolized to DPP during the first 72 h of zebrafish embryogenesis and (2) enhanced toxicity in the presence of BMS493 was not due to higher TPP doses relative to TPP-alone exposures. Rather, these data support the conclusion that TPP and BMS493 act synergistically within zebrafish embryos, possibly via direct or indirect interactions with RAR-relevant pathways.
Finally, based on our findings in zebrafish, we hypothesized that TPP may antagonize RA-induced activation of human RAR␣-, RAR␤-, or RAR␥. Using Chinese hamster ovary cells stably transfected with chimeric human RAR and luciferase reporter vectors, TPP significantly inhibited RA-induced luciferase activity in a concentration-dependent manner. Therefore, our data suggest that TPP has the potential to interact -albeit very weakly -with the ligand-binding domain of human RAR␣-, RAR␤-, or RAR␥. TPP is an agonist for human estrogen receptor ␣, estrogen receptor ␤, pregnane X receptor, and peroxisome proliferator-activated receptor (Belcher et al., 2014; Honkakoski et al., 2004; Kojima et al., 2013; Pillai et al., 2014) as well as an antagonist for human androgen receptor and glucocorticoid receptor (Kojima et al., 2013) . To our knowledge, this is the first study to identify TPP as a potential human RAR antagonist, supporting the emerging hypothesis that TPP -an industrial chemical that, unlike drugs and pesticides, was not designed to exhibit specificity and target a single class of receptors-may interact with multiple nuclear receptors localized within a diverse set of target tissues and organs.
In summary, our data collectively suggest that zebrafish RARs may be involved in mediating TPP-induced developmental toxicity, a mechanism of action that may have relevance to humans.
However, we recognize that additional research is needed to (1) confirm that TPP-induced toxicity in zebrafish embryos is RARdependent; (2) identify whether TPP-induced effects on cyp26a1 expression are localized to target organs such as the developing heart; and (3) identify RAR-dependent and RAR-independent pathways that may be affected by TPP during embryogenesis. Therefore, future studies should rely on RAR-specific morpholino oligos, cyp26a1-specific whole-mount in situ hybridizations, and whole genome expression profiling to better clarify the role of RAR-relevant pathways in mediating developmental toxicity. Nevertheless, our current findings continue to highlight the complexity of deciphering mechanisms of developmental toxicity for organophosphate-based flame retardants such as TPP in zebrafish and other vertebrates.
